ReviewAnemia2026
Prevalence and Risk of Anemia in People With Multiple Sclerosis (MS): A Systematic Review and Meta-Analysis.
Review in Anemia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Anemia appears as a common comorbidity in a different timing and underlying pathophysiology in people with MS (PwMS) and has been proposed as a prodrome finding in MS. This systematic review and meta-analysis aims to fulfill the need to clarify some characteristics of anemia in PwMS. Methods: A systematic literature search was performed using the MEDLINE PubMed, Scopus, and Google Scholar databases. Eligible studies underwent quality assessment using the Robins-E, and a meta-analysis of proportion was performed. The risk of anemia in PwMS versus healthy controls was calculated based on a subset of case-control studies. Reliability and robustness were assessed using leave-one-out analysis. Results: In a pool of 143,879 PwMS across 21 studies, anemia had a pooled prevalence of 12.5% (95% CI [8.1%, 17.7%], Conclusion: The intersection between anemia and MS presents a complex, multifaceted clinical challenge due to several pathophysiological mechanisms and DMT-related interactions. Further structured studies are needed to evaluate the exact underlying mechanisms and the directionality of this relationship.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.